Safe Discharge Sodium Level for Hyponatremia
Patients with hyponatremia should have a serum sodium level of at least 131 mmol/L before discharge, with optimal discharge levels between 138-142 mEq/L to minimize one-year mortality risk.
Target Sodium Level for Discharge
The neurosurgical guideline explicitly states that treatment should continue "until Na reaches 131 mmol/L" 1. This represents the minimum threshold for safe discharge in the guideline literature.
However, discharge sodium levels of 138-142 mEq/L are associated with the lowest one-year mortality, with significantly increased mortality risk when discharging patients with sodium ≤137 mEq/L (HR 1.43 for sodium ≤132 mEq/L) 2. This creates a U-shaped mortality curve, where both low and high discharge sodium levels predict worse outcomes.
Clinical Algorithm for Discharge Decision
Do not discharge if:
- Serum sodium <131 mEq/L (guideline minimum) 1
- Patient has persistent severe symptoms (altered mental status, seizures, nausea/vomiting)
- Sodium is still actively rising or unstable
Consider discharge when:
- Serum sodium ≥131 mEq/L AND asymptomatic 1
- Ideally, sodium has reached 138-142 mEq/L range 2
- Sodium level has been stable for at least 24 hours
- Underlying cause has been identified and addressed
Optimize before discharge:
- Target the 138-142 mEq/L range when possible, as this minimizes long-term mortality 2
- Patients discharged with sodium 133-137 mEq/L have acceptable but higher mortality risk compared to the optimal range
Important Caveats
Correction rate matters more acutely than discharge level: Recent high-quality evidence shows that faster correction rates (>12 mEq/L per 24 hours) are associated with lower 90-day mortality (9.0 percentage point reduction) compared to slow correction (<8 mEq/L per 24 hours) 3. The traditional fear of osmotic demyelination syndrome from rapid correction appears overstated, with meta-analysis showing rapid correction does not significantly increase ODS risk while reducing mortality by 32 per 1000 patients 4.
The guideline's 131 mEq/L threshold is conservative: While 1 provides the 131 mEq/L target, this was developed in 2009 for neurosurgical patients specifically. The more recent prognostic data 2 from 2020 involving 55,901 general hospitalized patients suggests aiming higher (138-142 mEq/L) when feasible improves long-term outcomes.
Avoid premature discharge: Discharging patients with sodium <131 mEq/L risks readmission and continued morbidity. The mortality risk is most pronounced in those discharged with sodium ≤132 mEq/L 2.
In practice, discharge patients when sodium reaches at least 131 mEq/L and symptoms have resolved, but strive for 138-142 mEq/L when clinically achievable to optimize long-term outcomes 1, 2.